Top Gainer for 2-16-23: $AMAM

in topgainers •  2 years ago 

Top Gainers_2023.02.16.jpeg

$AMAM - ARX517, Ambrx’s Proprietary Anti-PSMA ADC, Shows Encouraging Single-Agent Safety and Efficacy Data in Patients with Advanced Prostate Cancer: https://finance.yahoo.com/news/arx517-ambrx-proprietary-anti-psma-130000665.html

topgainers amam
2 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!